FDA.reportPublic FDA data

antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection

RxCUI
1719608
RxNorm name
antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
Display name
antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
Full name
antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125487EloctateAntihemophilic Factor (Recombinant), Fc Fusion protein351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e1419c33-ef07-4268-be1f-c8993502d597factor VIII (b-domain deleted recombinant) FC fusion protein 1 UNT Injection [PSN] · efmoroctocog alfa 1 UNT Injection [SCD] · antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection [SY]310These highlights do not include all the information needed to use ELOCTATE ® safely and effectively. See full prescribing information for ELOCTATE. ELOCTATE ® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 201420230505